Oncology Development Executive, Cheyanne, Wyoming

Labcorp is a global leader in laboratory services, providing the insights & answers that help healthcare providers, patients, researchers, pharmaceutical companies & health systems make confident decisions & improve outcomes. Through our unparalleled science, data, technology & laboratory network, we advance diagnostics, accelerate innovation & help address some of the world’s most important health challenges. As we shape the future of healthcare, we are leveraging advanced technologies, intelligent digital solutions & data-driven innovation across our operations to enhance how work gets done & deliver greater value to customers & patients.

With our global scale & deep expertise, you’ll have the opportunity to do meaningful work, grow your career & make a real impact on people’s health around the world. Together, we’re improving health & improving lives.

Oncology Development Executive, Cheyanne, Wyoming Labcorp is seeking a field-based Oncology Development Executive to join our team in the Cheyanne, Wyoming territory. The ideal person will be located within the territory.

• Business Development & Territory Growth Drive new business acquisition, competitive displacement, market penetration, & revenue growth across oncology practices, pathology groups, cancer centers, health systems, integrated delivery networks (IDNs), & academic medical centers.
• Develop and execute territory growth strategies that increase adoption of Labcorp's oncology diagnostics, hereditary cancer, & precision medicine portfolio.
• Achieve territory revenue, market share, new account, & growth objectives.
• Maintain accountability for opportunity management, pipeline development, forecasting accuracy, & sales performance through Salesforce CRM utilization.

• Establish relationships with physician leaders, pathology groups, cancer center administrators, health system stakeholders, & executive decision makers.
• Lead consultative sales engagements focused on oncology diagnostics, precision medicine adoption, operational efficiency, & testing strategy optimization.
• Develop enterprise growth plans that expand utilization across health systems, cancer networks, & academic medical centers.
• Influence testing pathways & adoption strategies within complex healthcare organizations.

• Represent Labcorp's oncology diagnostics, hereditary cancer, molecular diagnostics, genomic profiling, liquid biopsy, ctDNA, MRD, biomarker, NGS-based testing, pathology, hematopathology, cytogenetics, & virtual pathology solutions.
• Translate clinical, genomic, & scientific evidence into business-focused recommendations that support customer decision making.
• Maintain current knowledge of oncology diagnostics, hereditary cancer testing, molecular diagnostics, genomics, & precision medicine advancements.

• Coordinate field sales, national accounts, pathology, medical affairs, market access, operations, & executive leadership resources to support growth initiatives.
• Monitor competitive activity, market trends, & emerging oncology testing opportunities.

• HSD/GED equivalent with 9 years of experience; or Associate degree with 7 years experience; or Bachelor's degree with 5 years of experience; or Master's degree with 3 years of experience.
• 5 years of oncology sales, oncology diagnostics, molecular diagnostics, pharmaceutical oncology, biotechnology oncology, laboratory services, or precision medicine commercial experience
• 5 or more years of business development, territory management, or strategic account management experience
• 5 years selling into oncology practices, pathology groups, cancer centers, health systems, IDNs, or academic medical centers.

• Master's degree in Business Administration, Public Health, Life Sciences, Healthcare Administration, Pharmacy, or a scientific discipline.
• 3 years of oncology diagnostics, molecular diagnostics, genomics, hereditary cancer, precision medicine, companion diagnostics, liquid biopsy, or comprehensive genomic profiling experience.
• 3 years of experience commercializing NGS, molecular diagnostics, liquid…